{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T06:14:42Z","timestamp":1759385682664,"version":"build-2065373602"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>Ketamine is a rapid-acting antidepressant approved in the indication of treatment-resistant depression. As its clinical use expands, identifying underlying molecular mechanisms is essential. The serotonin transporter (SERT) is well known as a primary mechanism of several classes of monoaminergic antidepressants. Binding of ketamine to SERT has been observed <jats:italic>in vitro<\/jats:italic> and in animal studies with macaque monkeys using positron emission tomography (PET). We previously reported that a 0.5\u202fmg\/kg body weight dose of ketamine did not significantly bind to SERT in healthy human subjects assessed with PET but observed a positive trend between binding and ketamine plasma levels. Based on this finding, we hypothesized that a higher dose (0.8\u202fmg\/kg) would result in measurable SERT occupancy. Here, 10 healthy male participants were measured twice with [<jats:sup>11<\/jats:sup>C]DASB PET to test SERT occupancy following administration of 0.8\u202fmg\/kg body weight ketamine in four selected SERT rich regions amygdala, putamen, caudate and thalamus. Further, we implemented a bolus-plus-infusion radioligand infusion protocol and optimized the timing of the ketamine infusion. Contrary to our hypothesis, ketamine SERT occupancy did not significantly differ from zero, and the area under the curve of ketamine and norketamine plasma levels was not correlated with occupancy. These results suggest that even at doses up to 0.8\u202fmg\/kg, ketamine does not appreciably bind to SERT in humans, aligning with clinical observations that ketamine is routinely combined with serotonergic agents.<\/jats:p><jats:sec><jats:title>Clinical trial registration<\/jats:title><jats:p><jats:uri>http:\/\/clinicaltrials.gov<\/jats:uri>, identifier, NCT02582398. EUDAMED number, CIV-AT-13-01-009583.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnins.2025.1651016","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T05:33:28Z","timestamp":1759383208000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Human in vivo assessment of ketamine binding of the serotonin transporter\u2014follow up at a higher dose"],"prefix":"10.3389","volume":"19","author":[{"given":"G.","family":"Schlosser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Murga\u0161","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. M.","family":"Godbersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Reichel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Silberbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Nics","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Stimpfl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kasper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Rujescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Lanzenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Spies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.biopsych.2009.08.038","article-title":"Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression","volume":"67","author":"Aan Het Rot","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.tips.2021.08.003","article-title":"Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics","volume":"42","author":"Aleksandrova","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jpsychires.2022.04.037","article-title":"Real-world effectiveness of ketamine in treatment-resistant depression: a systematic review & meta-analysis","volume":"151","author":"Alnefeesi","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1476-5381.1983.tb11031.x","article-title":"The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate","volume":"79","author":"Anis","year":"1983","journal-title":"Br. J. Pharmacol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jad.2020.09.071","article-title":"Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis","volume":"278","author":"Bahji","year":"2021","journal-title":"J. Affect. Disord."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/j.euroneuro.2015.07.021","article-title":"Combination of intravenous S-ketamine and oral tranylcypromine in treatment-resistant depression: a report of two cases","volume":"25","author":"Bartova","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/s0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/s41380-023-02397-1","article-title":"Targeting metaplasticity mechanisms to promote sustained antidepressant actions","volume":"29","author":"Brown","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.euroneuro.2016.08.009","article-title":"Ketamine modulates catecholamine transmission in the bed nucleus of stria terminalis: the possible role of this region in the antidepressant effects of ketamine","volume":"26","author":"Cadeddu","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e0256390","DOI":"10.1371\/journal.pone.0256390","article-title":"Subanesthetic ketamine rapidly alters medial prefrontal miRNAs involved in ubiquitin-mediated proteolysis","volume":"16","author":"Choi","year":"2021","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.jadohealth.2021.08.026","article-title":"Prevalence of depression among adolescents in the U.S. from 2009 to 2019: analysis of trends by sex, race\/ethnicity, and income","volume":"70","author":"Daly","year":"2022","journal-title":"J. Adolesc. Health"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1001\/jamapsychiatry.2019.1189","article-title":"Efficacy of Esketamine nasal spray plus Oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial","volume":"76","author":"Daly","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0304-3940(88)90063-8","article-title":"Ketamine blocks an NMDA receptor-mediated component of synaptic transmission in rat hippocampus in a voltage-dependent manner","volume":"92","author":"Davies","year":"1988","journal-title":"Neurosci. Lett."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3109\/00498254.2012.685777","article-title":"Stereoselective and regiospecific hydroxylation of ketamine and norketamine","volume":"42","author":"Desta","year":"2012","journal-title":"Xenobiotica; the Fate of Foreign Compounds in Biological Systems"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1007\/s00213-016-4327-5","article-title":"Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression","volume":"233","author":"du Jardin","year":"2016","journal-title":"Psychopharmacology"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.neuron.2024.11.011","article-title":"Ketamine induces plasticity in a norepinephrine-astroglial circuit to promote behavioral perseverance","volume":"113","author":"Duque","year":"2025","journal-title":"Neuron"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41380-018-0256-5","article-title":"Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)","volume":"25","author":"Fava","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/ijnp\/pyz039","article-title":"Efficacy and safety of fixed-dose Esketamine nasal spray combined with a new Oral antidepressant in treatment-resistant depression: results of a randomized, double-blind, active-controlled study (TRANSFORM-1)","volume":"22","author":"Fedgchin","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1523\/JNEUROSCI.1104-20.2020","article-title":"Brain-derived neurotrophic factor\/tropomyosin receptor kinase B signaling controls excitability and long-term depression in oval nucleus of the BNST","volume":"41","author":"Fiedler","year":"2021","journal-title":"J. Neurosci."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1172\/JCI130808","article-title":"GABA interneurons are the cellular trigger for ketamine\u2019s rapid antidepressant actions","volume":"130","author":"Gerhard","year":"2020","journal-title":"J. Clin. Invest."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00213-013-3024-x","article-title":"Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism","volume":"228","author":"Gigliucci","year":"2013","journal-title":"Psychopharmacology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neuroimage.2017.01.050","article-title":"Simple and rapid quantification of serotonin transporter binding using [11C]DASB bolus plus constant infusion","volume":"149","author":"Gryglewski","year":"2017","journal-title":"NeuroImage"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1097\/ALN.0000000000003577","article-title":"Ketamine pharmacokinetics","volume":"133","author":"Kamp","year":"2020","journal-title":"Anesthesiology"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.nucmedbio.2004.10.001","article-title":"Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region?","volume":"32","author":"Kish","year":"2005","journal-title":"Nucl. Med. Biol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/mp.2017.190","article-title":"The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders","volume":"23","author":"Kokkinou","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.biopsych.2014.09.010","article-title":"High-dose testosterone treatment increases serotonin transporter binding in transgender people","volume":"78","author":"Kranz","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e2327331","DOI":"10.1001\/jamanetworkopen.2023.27331","article-title":"Measures of connectivity and dorsolateral prefrontal cortex volumes and depressive symptoms following treatment with selective serotonin reuptake inhibitors in adolescents","volume":"6","author":"Lee","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.bbr.2014.11.016","article-title":"Dopamine D2\/D3 but not dopamine D1 receptors are involved in the rapid antidepressant-like effects of ketamine in the forced swim test","volume":"279","author":"Li","year":"2015","journal-title":"Behav. Brain Res."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jpsychires.2019.08.002","article-title":"Changes in the global burden of depression from 1990 to 2017: findings from the global burden of disease study","volume":"126","author":"Liu","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.pharmthera.2015.01.009","article-title":"Structure and function of serotonin G protein coupled receptors","volume":"150","author":"McCorvy","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1176\/appi.ajp.161.5.826","article-title":"Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study","volume":"161","author":"Meyer","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"eaat8078","DOI":"10.1126\/science.aat8078","article-title":"Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation","volume":"364","author":"Moda-Sava","year":"2019","journal-title":"Science"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/00000542-199803000-00029","article-title":"Ketamine inhibits monoamine transporters expressed in human embryonic kidney 293 cells","volume":"88","author":"Nishimura","year":"1998","journal-title":"Anesthesiology"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jagp.2019.10.008","article-title":"Efficacy and safety of Esketamine nasal spray plus an Oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3","volume":"28","author":"Ochs-Ross","year":"2020","journal-title":"American J. Geriatric Psychiatry: Official J. American Ass. Geriatric Psychiatry"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.neuropharm.2016.05.010","article-title":"Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB\/cJ mice","volume":"112","author":"Pham","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/da.22253","article-title":"Effects of ketamine on EXPLICIT and IMPLICIT suicidal cognition: a randomized controlled trial in treatment-resistant depression","volume":"31","author":"Price","year":"2014","journal-title":"Depress. Anxiety"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.biopsych.2009.04.029","article-title":"Effects of intravenous ketamine on Explicit and Implicit measures of suicidality in treatment-resistant depression","volume":"66","author":"Price","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1097\/ALN.0000000000001392","article-title":"Role of cytochrome P4502B6 polymorphisms in ketamine metabolism and clearance","volume":"125","author":"Rao","year":"2016","journal-title":"Anesthesiology"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.psychres.2015.10.032","article-title":"Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression","volume":"230","author":"Romeo","year":"2015","journal-title":"Psychiatry Res."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1007\/s00726-011-1078-9","article-title":"Serotonin and molecular neuroimaging in humans using PET","volume":"42","author":"Saulin","year":"2012","journal-title":"Amino Acids"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.jad.2024.03.137","article-title":"Efficacy of intravenous ketamine and intranasal esketamine with dose escalation for major depression: a systematic review and meta-analysis","volume":"356","author":"Seshadri","year":"2024","journal-title":"J. Affect. Disord."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"549903","DOI":"10.3389\/fpsyt.2020.549903","article-title":"Effect of ketamine on limbic GABA and glutamate: a human in vivo multivoxel magnetic resonance spectroscopy study","volume":"11","author":"Silberbauer","year":"2020","journal-title":"Front. Psychol."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/515180a","article-title":"Mental health: a world of depression","volume":"515","author":"Smith","year":"2014","journal-title":"Nature"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1524\/ract.92.4.341.35597","article-title":"Determination of reaction parameters for the synthesis of the serotonin transporter ligand [11C]DASB: application to a remotely controlled high yield synthesis","volume":"92","author":"Solbach","year":"2004","journal-title":"Radiochim. Acta"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/ijnp\/pyx085","article-title":"Assessment of ketamine binding of the serotonin transporter in humans with positron emission tomography","volume":"21","author":"Spies","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref46","volume-title":"[11C]N,N-Dimethyl-2-(2\u2032-amino-4\u2032-hydroxymethylphenylthio)benzylamine, in molecular imaging and contrast agent database (MICAD)","year":"2004"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2967\/jnumed.115.163683","article-title":"In vivo evaluation of 11C-DASB for quantitative SERT imaging in rats and mice","volume":"57","author":"Walker","year":"2016","journal-title":"J. Nuclear Med.: Official Pub., Society of Nuclear Med."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1038\/npp.2013.176","article-title":"Subanesthetic doses of ketamine transiently decrease serotonin transporter activity: a PET study in conscious monkeys","volume":"38","author":"Yamamoto","year":"2013","journal-title":"Neuropsychopharmacol."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.1038\/tp.2013.112","article-title":"A possible mechanism of the nucleus accumbens and ventral pallidum 5-HT1B receptors underlying the antidepressant action of ketamine: a PET study with macaques","volume":"4","author":"Yamanaka","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1523\/JNEUROSCI.1316-22.2022","article-title":"NMDA receptor activation-dependent antidepressant-relevant behavioral and synaptic actions of ketamine","volume":"43","author":"Zanos","year":"2023","journal-title":"J. Neurosci."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0014-2999(92)90248-3","article-title":"Differential effects of ketamine enantiomers on NMDA receptor currents in cultured neurons","volume":"213","author":"Zeilhofer","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.jocn.2007.11.007","article-title":"Antidepressants modulate the in vitro inhibitory effects of propofol and ketamine on norepinephrine and serotonin transporter function","volume":"15","author":"Zhao","year":"2008","journal-title":"J. Clin. Neurosci.: Official J. Neurosurg. Society Australasia"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2025.1651016\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T05:33:30Z","timestamp":1759383210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2025.1651016\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":55,"alternative-id":["10.3389\/fnins.2025.1651016"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2025.1651016","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"article-number":"1651016"}}